- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04585360
Psychiatric Manifestations Associated With Behcet's Disease (PSYCHO-B7)
October 9, 2020 updated by: Assistance Publique - Hôpitaux de Paris
The psychoBehçet'study is aimed at evaluating the psychological and neurocognitive symptoms in 25 consecutive patients followed for Behçet's disease.
This is a monocentric, observational, non interventional study.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Patients will be evaluated during a day-care facility for Behçet's disease activity together with evaluation of anxiety and depression symptoms (SCL90-R and MINI assessments), fatigue (MFI) and quality of life (SF36).
Study Type
Observational
Enrollment (Anticipated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nicolas NN NOEL, MD PhD
- Phone Number: + 33 1 45 21 27 57
- Email: nicolas.noel@aphp.fr
Study Contact Backup
- Name: Fanny FU URBAIN, MD
- Phone Number: + 33 1 45 21 27 57
- Email: fanny.urbain@aphp.fr
Study Locations
-
-
Val De Marne
-
Le Kremlin-Bicetre, Val De Marne, France, 94275
- Internal medecine department
-
Contact:
- Nicolas NOEL, MD, PhD
- Phone Number: + 331 45 21 27 57
- Email: nicolas.noel@aphp.fr
-
Contact:
- Fanny URBAIN, MD
- Phone Number: + 33 1 45 21 27 57
- Email: fanny.urbain@aphp.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patient regularly monitored in the internal medicine department of Bicêtre
Description
Inclusion Criteria:
- Adult male or female
- Regular follow-up in the internal medicine department of Bicetre hospital
- Diagnosed with Behçet's disease
Exclusion Criteria:
- Refusal to participate in the study
- Poor command of the French language
- Patients under legal protection
- Pregnant woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patient with Behcet disease
adult patient with Behcet's disease followed regularly in the internal medicine department of Bicetre
|
Realization of specific questionnaires evaluating:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SCL90-R questionnaire
Time Frame: Inclusion visit
|
Anxiety/depression symptoms questionnaire
|
Inclusion visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MINI questionnaire
Time Frame: Inclusion visit
|
Anxiety/depression symptoms questionnaire
|
Inclusion visit
|
MFI questionnaire
Time Frame: Inclusion visit
|
Tiredness assessment
|
Inclusion visit
|
SF36 questionnaire
Time Frame: Inclusion visit
|
Quality of life
|
Inclusion visit
|
BSAS/BDCAF evaluation
Time Frame: Inclusion visit
|
Behçet's disease activity
|
Inclusion visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: NOEL NN Nicolas, MD PhD, APHP, Hôpital Bicetre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 10, 2020
Primary Completion (Anticipated)
February 15, 2021
Study Completion (Anticipated)
February 15, 2021
Study Registration Dates
First Submitted
October 9, 2020
First Submitted That Met QC Criteria
October 9, 2020
First Posted (Actual)
October 14, 2020
Study Record Updates
Last Update Posted (Actual)
October 14, 2020
Last Update Submitted That Met QC Criteria
October 9, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-A01819-48
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behçet's Disease, neuroBehcet, Anxiety, Depression, Tiredness
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
Babes-Bolyai UniversityCompletedGeneralized Anxiety Disorder | Social Anxiety | Panic Disorder | Specific Phobia | Major Depression MildRomania
-
Assiut UniversityNot yet recruiting
-
Douglas MenninWeill Medical College of Cornell University; Kent State UniversityCompletedGeneralized Anxiety Disorder | Depression, Anxiety | Anxiety Disorders and Symptoms | Emotional DysfunctionUnited States
-
National Institute of Mental Health (NIMH)CompletedDepression | Anxiety Disorders | Major Depression | Unipolar Depression | Anxiety DisorderUnited States
-
Aga Khan UniversityNot yet recruitingAnxiety Disorders | Mental Disorder in Adolescence | Depression in AdolescencePakistan
-
University of HoustonNational Institute on Drug Abuse (NIDA)CompletedSmoking | Anxiety Disorders | Depression DisordersUnited States
-
University of ArizonaUnknownDepression | Obsessive-Compulsive Disorder | Generalized Anxiety Disorder
-
Psychiatric Research Unit, Region Zealand, DenmarkAarhus University Hospital; University of Copenhagen; Mental Health Centre CopenhagenCompletedPanic Disorder | Depression, Unipolar | Anxiety Disorder SocialDenmark
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepression | Generalized Anxiety Disorder | Panic DisorderUnited States
Clinical Trials on Questionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life
-
Sohag UniversityNot yet recruitingPatients With Multiple SclerosisEgypt
-
M.D. Anderson Cancer CenterCompleted
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento... and other collaboratorsCompletedCOVID-19 | SARS-CoV-2 InfectionBrazil
-
Istanbul University - Cerrahpasa (IUC)CompletedHeadache Disorders | Chronic Pain Syndrome | Fibromyalgia Syndrome | Chronic Migraine, Headache | Central SensitisationTurkey
-
Instituto do Cancer do Estado de São PauloCompleted
-
Trakya UniversityCompletedQuality of Life | Rheumatoid Arthritis | Depression, Anxiety | Nurse's RoleTurkey
-
University of ChicagoActive, not recruitingCovid-19 | Critical Illness | Respiratory Failure | Corona Virus InfectionUnited States
-
Assiut UniversityCompleted
-
Assistance Publique Hopitaux De MarseilleCompletedHypercorticismFrance
-
Bogomolets National Medical UniversityCompletedChronic Pain | Psychological DisordersUkraine